The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer
- PMID: 6184098
- DOI: 10.1007/BF01807891
The interpretation of trials: combined hormonal therapy and chemotherapy in disseminated breast cancer
Similar articles
-
Combined chemo-hormonal therapy in breast cancer: a hypothesis.Breast Cancer Res Treat. 1981;1(2):121-3. doi: 10.1007/BF01805864. Breast Cancer Res Treat. 1981. PMID: 7348568
-
[Estrogen antagonists and inhibitors in hormone therapy of breast cancer].Vopr Onkol. 1989;35(7):771-8. Vopr Onkol. 1989. PMID: 2528239 Review. Russian. No abstract available.
-
The duration of adjuvant tamoxifen therapy.Cancer Treat Res. 1998;94:181-93. doi: 10.1007/978-1-4615-6189-7_10. Cancer Treat Res. 1998. PMID: 9587688 Review. No abstract available.
-
Tamoxifen in early breast cancer.Lancet. 1998 Aug 1;352(9125):403. doi: 10.1016/S0140-6736(05)60500-4. Lancet. 1998. PMID: 9717952 No abstract available.
-
Introduction to chemotherapy and antineoplastic pharmacology in breast cancer.Eur J Gynaecol Oncol. 1982;3(1):14-23. Eur J Gynaecol Oncol. 1982. PMID: 6184231 Review. No abstract available.
Cited by
-
Combined chemo-hormonal therapy in breast cancer: a hypothesis.Breast Cancer Res Treat. 1981;1(2):121-3. doi: 10.1007/BF01805864. Breast Cancer Res Treat. 1981. PMID: 7348568
-
An assessment of current achievements in the systemic management of breast cancer.Breast Cancer Res Treat. 1984;4(2):69-77. doi: 10.1007/BF01806388. Breast Cancer Res Treat. 1984. PMID: 6378282 Review.
-
Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.Br J Cancer. 1985 Mar;51(3):365-9. doi: 10.1038/bjc.1985.48. Br J Cancer. 1985. PMID: 3970812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical